Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients

Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. BioGaia´ s Investment In Far East Gives Results Chichiyasu Co. Ltd in Hiroshima has been BioGaia´s licensee for dairy products in Japan, in an expired contract which has now been renegotiated on improved terms. Caompany has also signed an agreement with Biolife in Malaysia for the distribution of Biogaia´s oil drops for children through pharmacies, as well as an agreement with Age D'Or Health Care in Singapore for distribution of oil drops and tablets. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Tate & Lyle, the global renewable ingredients company, today announced the completion of the acquisition of the US specialty food ingredients company Continental Custom Ingredients (“CCI”). This follows the initial acquisition announcement of 5 December 2005. CCI was founded in 1975, with headquarters and primary operations in Sycamore, Illinois. It also has operations in Mexico and Canada. CCI is a recognised leader in dairy stabilisers and emulsifier systems and works closely with customers to develop ingredient systems for the North American market. CCI also has expertise in beverage flavours and vitamin and mineral fortification. CCI will now trade as Tate & Lyle Custom Ingredients. D Lynn Grider, President of Tate & Lyle, Food & Industrial Ingredients, Americas said, “We are focused on delivering ingredient solutions to our customers and have identified the dairy industry as a key growth area. The acquisition of CCI enables us to advance these initiatives by bringing to Tate & Lyle new expertise in the areas of dairy stabilisers, hydrocolloids systems, emulsifiers, vitamins and flavours. Additionally, CCI has an established sourcing network which will enable us to develop ingredient systems with an even broader range of functional food ingredients. CCI's dairy knowledge and blending operations compliment our fundamental ingredient technologies and operational efficiencies, enabling us to provide our customers with an even greater level of service and an increased range of innovative products.” Ray Minzner, Chief Executive Officer of CCI (who will become President - Tate & Lyle Custom Ingredients) said, “We have been a customer of Tate & Lyle for many years and are pleased to build upon our relationship. Being part of a global ingredients business will promote faster growth, open up international markets, and ensure we realize the full potential of our strong team and our new facility in Sycamore, Illinois. We very much look forward to our future as part of a company which has global reach but which values community relationships." Tom Doxsie, Senior Vice President, Food Ingredients, Tate & Lyle, Food & Industrial Ingredients, Americas said, “The addition of CCI to Tate & Lyle vertically integrates us closer to our shared customer base and to the dairy industry. The combination of our Research & Development expertise and broad ingredient portfolio, coupled with CCI's intimate dairy knowledge, speed and agility to market, provides a solid foundation for growth.” About Tate & Lyle Tate & Lyle is a world leading manufacturer of renewable food and industrial ingredients. It uses innovative technology to transform corn, wheat and sugar into value-added ingredients for customers in the food, beverage, pharmaceutical, cosmetic, paper, packaging and building industries. The Company is a leader in cereal sweeteners and starches, sugar refining, value added food and industrial ingredients, and citric acid. Tate & Lyle is the world number-one in industrial starches and is the sole manufacturer of SPLENDA® Sucralose. Headquartered in London, Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. In the US its ADRs trade under TATYY. The Company operates more than 60 production facilities in 28 countries, throughout Europe, the Americas and South East Asia. It employs 6,700 people in its subsidiaries with a further 4,500 employed in joint ventures. Sales in the year to 31 March 2005 totalled £3.3 billion. Additional information can be found on this website www.tateandlyle.com. SPLENDA® and the SPLENDA® logo are trademarks of McNeil Nutritionals, LLC
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software